Mobileye Faces Downgrade from UBS with Growth Concerns
Mobileye Global (NASDAQ: MBLY) has recently received a downgrade from UBS, moving from a 'Buy' to a 'Neutral' rating. With the new price target set at $14, it marks a significant decrease from the previous target of $20.
Long-Term Potential versus Short-Term Challenges
UBS analysts suggest that while Mobileye has long-term potential to become a significant partner for automotive manufacturers outside of China, the timeline for a substantial growth return has lengthened beyond earlier forecasts.
Expectations for 2025
UBS views 2025 as a pivotal year for Mobileye, predicting that consensus revenue estimates might need to be revised downwards significantly. Their projections indicate that Mobileye's revenue for 2025 to 2027 is likely to fall approximately 28% short of what most analysts have anticipated.
Market Conditions and Future Growth Outlook
According to UBS, the current market conditions could lead Mobileye's stock to stagnate until a 'reset' phase is achieved. The involvement of Intel (NASDAQ: INTC) as a significant shareholder also contributes to uncertainties surrounding the company's trajectory.
Challenges with SuperVision Technology
A major factor influencing the downgrade is the slower growth expectations for Mobileye's SuperVision (SV) system, which was seen as a critical part of the company's narrative. UBS analysts noted, "While MBLY's growth initially relied on the higher-priced L2+ SuperVision system, main customer Zeekr has opted for an in-house solution, thus limiting volume growth."
Impact of Recent Developments
Concerns continue to mount regarding upcoming customers for the SuperVision system, including manufacturers such as FAW and Polestar (NASDAQ: PSNY). As a result, UBS has reduced its forecast for SuperVision unit sales in 2025 by a substantial 40%, projecting only 71,000 units.
Future Projections: 2026 and Beyond
Despite hopes for a rebound in SuperVision sales as Volkswagen (ETR: VOWG_p) is expected to come onboard, UBS remains cautious about predicting increased unit sales for the next two years compared to broader market consensus. Sales acceleration is not anticipated until 2026.
Sign of a Shift in Potential
UBS is clear in their stance: for their outlook to change, they would need to observe a quicker adoption of Mobileye's advanced technologies. This would likely stem from legacy automakers intensifying competition against leaders like Tesla (NASDAQ: TSLA) and emerging OEMs from China. Although potential positive announcements could arise by the year-end, real shifts are expected more likely in 2025.
Conclusion: Cautious Approach Recommended
Given the myriad of uncertainties and the challenges posed to growth, UBS leans towards a cautious stance on Mobileye. The landscape is shifting, and the road to recovery may be long and winding.
Frequently Asked Questions
What led to UBS downgrading Mobileye's stock?
UBS downgraded Mobileye due to longer than expected growth timelines and significant challenges, especially related to its SuperVision technology.
What are UBS's revenue projections for Mobileye from 2025 to 2027?
UBS predicts that Mobileye's revenue will likely fall about 28% below current consensus estimates during this period.
What challenges are impacting Mobileye's growth story?
A key challenge is the adoption of the SuperVision system by major automotive partners like Zeekr, which has chosen an in-house solution instead.
When does UBS expect Mobileye to see a re-acceleration in sales?
UBS expects a potential sales acceleration in 2026, primarily driven by contracts with automakers like Volkswagen.
How might competition from other automakers affect Mobileye?
Increased competition from legacy automakers against leaders like Tesla could drive faster adoption of Mobileye's advanced products, impacting its growth positively.
